1,3,4-oxadiazole has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bai, CG; Chen, Y; Chu, XQ; Ding, YH; Li, HY; Li, YT; Meng, FF; Pan, CW; Qu, WZ; Wang, JH; Yang, C; Zhang, Q | 1 |
Ananth, AH; Bhattacharjee, A; Elancheran, R; Kabilan, S; Lakshmithendral, K; Manikandan, N; Rajan, RK; Ramanathan, M | 1 |
2 other study(ies) available for 1,3,4-oxadiazole and imatinib mesylate
Article | Year |
---|---|
Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Triazoles | 2016 |
Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Breast Neoplasms; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferase 1; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogen Receptor alpha; Female; Humans; Imatinib Mesylate; Molecular Conformation; Molecular Docking Simulation; Oxadiazoles; Structure-Activity Relationship | 2020 |